Scio-323

CAS No. 309913-51-7

Scio-323( —— )

Catalog No. M36224 CAS No. 309913-51-7

Scio-323 is an orally available p38 mitogen-activated protein (MAPK) kinase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 206 In Stock
5MG 172 In Stock
10MG 254 In Stock
25MG 392 In Stock
50MG 531 In Stock
100MG 710 In Stock
200MG 958 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Scio-323
  • Note
    Research use only, not for human use.
  • Brief Description
    Scio-323 is an orally available p38 mitogen-activated protein (MAPK) kinase inhibitor.
  • Description
    Scio-323 is an orally available p38 mitogen-activated protein (MAPK) kinase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    p38 MAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    309913-51-7
  • Formula Weight
    479.54
  • Molecular Formula
    C27H30FN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(N(C)C)=O)(=O)C=1C=2C(=CC(OC)=C(C(=O)N3CCC(CC4=CC=C(F)C=C4)CC3)C2)N(C)C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Nek2-IN-5

    Nek2-IN-5 (NCL00017509) is a potent and selective inhibitor of NIMA-related kinase 2 (Nek2).

  • SB-242235

    A selective p38 MAPK inhibitor; inhibits IL-1 beta induction of p38 MAPK in primary human chondrocytes with IC50 of 1 uM.

  • RWJ 67657

    A potent, selective, orally active p38 MAPK inhibitor that inhibits the production of TNF-α and IL-1β by LPS-stimulated human PBMCs with IC50 of 3 and 11 nM, respectively.